The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malek, T. R.
Right arrow Articles by Codias, E. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malek, T. R.
Right arrow Articles by Codias, E. K.
The Journal of Immunology, 2001, 166: 1675-1683.
Copyright © 2001 by The American Association of Immunologists

Broad Programming by IL-2 Receptor Signaling for Extended Growth to Multiple Cytokines and Functional Maturation of Antigen-Activated T Cells1

Thomas R. Malek2, Aixin Yu, Paul Scibelli, Mathias G. Lichtenheld and Elaine K. Codias

Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136

Coincident production of IL-2 and induction of high-affinity IL-2R upon TCR engagement has precluded a clear distinction for the biological outcome of signaling through TCR/costimulatory molecules vs the IL-2R. Using a novel transgenic mouse on the IL-2R{beta}-/- genetic background, this study has separated the relative outcome of signaling through the TCR and IL-2R. We show that stimulation through the TCR and CD28 or CD40 ligand directly leads to T cell activation and several rounds of proliferation in an IL-2-independent fashion. However, this stimulation is insufficient for extended T cell growth to multiple cytokines or differentiation into CTL or IFN-{gamma}-secreting effector T cells. IL-2 is required for these functions in part by regulation of cyclin D3 and granzyme B. Somewhat less efficiently, IL-4 stimulation of these transgenic T cells redundantly rescued many of these activities. These data demonstrate a fundamental requirement for IL-2 and perhaps other common {gamma}-chain-dependent cytokines to promote selective gene expression by Ag-activated T cells for their subsequent growth and differentiation into effector T lymphocytes.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. L. Bayer, J. Y. Lee, A. de la Barrera, C. D. Surh, and T. R. Malek
A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells
J. Immunol., July 1, 2008; 181(1): 225 - 234.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Williams, S. E. Murray, A. D. Weinberg, and D. C. Parker
OX40-Mediated Differentiation to Effector Function Requires IL-2 Receptor Signaling but Not CD28, CD40, IL-12Rbeta2, or T-bet
J. Immunol., June 15, 2007; 178(12): 7694 - 7702.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Bayer, A. Yu, and T. R. Malek
Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells
J. Immunol., April 1, 2007; 178(7): 4062 - 4071.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Gong and T. R. Malek
Cytokine-Dependent Blimp-1 Expression in Activated T Cells Inhibits IL-2 Production
J. Immunol., January 1, 2007; 178(1): 242 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Engedal, T. Gjevik, R. Blomhoff, and H. K. Blomhoff
All-trans Retinoic Acid Stimulates IL-2-Mediated Proliferation of Human T Lymphocytes: Early Induction of Cyclin D3.
J. Immunol., September 1, 2006; 177(5): 2851 - 2861.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. H. Cornish, L. V. Sinclair, and D. A. Cantrell
Differential regulation of T-cell growth by IL-2 and IL-15
Blood, July 15, 2006; 108(2): 600 - 608.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Verdeil, D. Puthier, C. Nguyen, A.-M. Schmitt-Verhulst, and N. Auphan-Anezin
STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors.
J. Immunol., April 15, 2006; 176(8): 4834 - 4842.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
H. Jin, D. Gong, D. Adeegbe, A. L. Bayer, C. Rolle, A. Yu, and T. R. Malek
Quantitative assessment concerning the contribution of IL-2R{beta} for superantigen-mediated T cell responses in vivo
Int. Immunol., April 1, 2006; 18(4): 565 - 572.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
F. Gesbert, J.-L. Moreau, and J. Theze
IL-2 Responsiveness of CD4 and CD8 lymphocytes: further investigations with human IL-2R{beta} transgenic mice
Int. Immunol., August 1, 2005; 17(8): 1093 - 1102.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Teague, R. M. Tempero, S. Thomas, K. Murali-Krishna, and B. H. Nelson
Proliferation and Differentiation of CD8+ T Cells in the Absence of IL-2/15 Receptor {beta}-Chain Expression or STAT5 Activation
J. Immunol., September 1, 2004; 173(5): 3131 - 3139.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. Vu, F. Amanullah, Y. Li, G. Demirci, M. H. Sayegh, and X. C. Li
Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection
J. Immunol., July 1, 2004; 173(1): 214 - 221.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Carrio, O. F. Bathe, and T. R. Malek
Initial Antigen Encounter Programs CD8+ T Cells Competent to Develop into Memory Cells That Are Activated in an Antigen-Free, IL-7- and IL-15-Rich Environment
J. Immunol., June 15, 2004; 172(12): 7315 - 7323.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. K. Lathrop, C. A. Huddleston, P. A. Dullforce, M. J. Montfort, A. D. Weinberg, and D. C. Parker
A Signal through OX40 (CD134) Allows Anergic, Autoreactive T Cells to Acquire Effector Cell Functions
J. Immunol., June 1, 2004; 172(11): 6735 - 6743.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Dooms, E. Kahn, B. Knoechel, and A. K. Abbas
IL-2 Induces a Competitive Survival Advantage in T Lymphocytes
J. Immunol., May 15, 2004; 172(10): 5973 - 5979.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
B. Sawitzki, B. Kieselbach, M. Fisser, C. Meisel, K. Vogt, M. Gaestel, M. Lehmann, K. Risch, G. Grutz, and H.-D. Volk
IFN-{gamma} Regulation in Anti-CD4 Antibody-Induced T Cell Unresponsiveness
J. Am. Soc. Nephrol., March 1, 2004; 15(3): 695 - 703.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Wong and E. G. Pamer
Disparate In Vitro and In Vivo Requirements for IL-2 During Antigen-Independent CD8 T Cell Expansion
J. Immunol., February 15, 2004; 172(4): 2171 - 2176.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. R. Malek
The main function of IL-2 is to promote the development of T regulatory cells
J. Leukoc. Biol., December 1, 2003; 74(6): 961 - 965.
[Abstract] [Full Text]


Home page
J. Virol.Home page
M. J. Trifilo, C. C. Bergmann, W. A. Kuziel, and T. E. Lane
CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection
J. Virol., April 1, 2003; 77(7): 4004 - 4014.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yu, J. Zhou, N. Marten, C. C. Bergmann, M. Mammolenti, R. B. Levy, and T. R. Malek
Efficient Induction of Primary and Secondary T Cell-Dependent Immune Responses In Vivo in the Absence of Functional IL-2 and IL-15 Receptors
J. Immunol., January 1, 2003; 170(1): 236 - 242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Colombetti, F. Benigni, V. Basso, and A. Mondino
Clonal Anergy Is Maintained Independently of T Cell Proliferation
J. Immunol., December 1, 2002; 169(11): 6178 - 6186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. J. Borron, E. A. Mostaghel, C. Doyle, E. S. Walsh, M. G. McHeyzer-Williams, and J. R. Wright
Pulmonary Surfactant Proteins A and D Directly Suppress CD3+/CD4+ Cell Function: Evidence for Two Shared Mechanisms
J. Immunol., November 15, 2002; 169(10): 5844 - 5850.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li
On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response
J. Immunol., May 1, 2002; 168(9): 4382 - 4390.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. B. Han, S. H. Park, Y. J. Jeon, Y. K. Kim, H. M. Kim, and K. H. Yang
Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Ralpha Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis
J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 415 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. F. Bathe, N. Dalyot-Herman, and T. R. Malek
IL-2 During In Vitro Priming Promotes Subsequent Engraftment and Successful Adoptive Tumor Immunotherapy by Persistent Memory Phenotypic CD8+ T Cells
J. Immunol., October 15, 2001; 167(8): 4511 - 4517.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Min, K. L. Legge, J. J. Bell, R. K. Gregg, L. Li, J. C. Caprio, and H. Zaghouani
Neonatal Exposure to Antigen Induces a Defective CD40 Ligand Expression that Undermines Both IL-12 Production by APC and IL-2 Receptor Up-Regulation on Splenic T Cells and Perpetuates IFN-{{gamma}}-Dependent T Cell Anergy
J. Immunol., May 1, 2001; 166(9): 5594 - 5603.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.